MedTrace Logo

Dynamics of Fatigue and Recovery in MMA Training

NCT06709599 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-06-25

No results posted yet for this study

Summary

This observational study aims to understand how strength and conditioning training impacts biochemical and psychological markers of fatigue and recovery in mixed martial arts (MMA) athletes. The main questions it aims to answer are:

How does a high-intensity training program affect key biochemical markers, such as cortisol, inflammation, and muscle damage indicators? How does this training influence psychological factors, such as stress, mood, and recovery states? Researchers will compare measurements taken at four time points during the study to see if the training program leads to changes in these markers and whether it effectively balances stress and recovery.

Participants will:

Undergo a structured strength and conditioning program for three weeks. Provide blood samples for biochemical analysis at four different times. Complete psychological questionnaires assessing mood, stress, and recovery states.

The findings aim to help optimize training programs and improve athlete well-being while minimizing the risk of overtraining.

Conditions

  • Healthy

Interventions

OTHER

Three-Week Strength and Conditioning Program

Athletes train six days a week for three weeks, totaling approximately 15 hours of training per week. Training includes circuit training, weightlifting, technique drills, and sparring, designed to mimic typical MMA preparation.

Sponsors & Collaborators

  • Poznan University of Physical Education

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-06
Primary Completion
2014-09-20
Completion
2015-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06709599 on ClinicalTrials.gov